Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Hematology

How Often Should I Have Blood Tests to Monitor PNH?

At a Glance

PNH blood-test schedules are individualized: testing may be every few weeks or monthly when starting treatment or symptoms are active, then every 3 to 6 months when stable. Flow cytometry may be done about once a year or sooner if results or symptoms change.

There is no single “one-size-fits-all” schedule for blood tests when you have Paroxysmal Nocturnal Hemoglobinuria (PNH). The frequency of your blood draws will be personalized by your hematologist based on the severity of your anemia, the treatments you are receiving, and any symptoms you are experiencing [1].

While your doctor will set your exact schedule, a typical monitoring framework often looks like this:

  • Starting treatment or during active symptoms: Blood tests may be needed frequently, such as every few weeks or monthly, to ensure medications are working and levels are stabilizing [1][2].
  • Stable follow-up: If your disease is well-controlled, routine testing might only be needed every 3 to 6 months [1].
  • Pregnancy: Requires very close, individualized monitoring (often coordinated with a maternal-fetal-medicine team) because pregnancy places significant stress on the body and increases the risk of complications [3].

Routine Blood Work: What is Checked?

When you go in for a routine blood test, your doctor is looking at specific markers to see how active your PNH is. It is important to know that no single test tells the whole story; your doctor interprets these results together [4].

  • Complete Blood Count (CBC): This measures your red blood cells, white blood cells, and platelets. It helps check for anemia and monitors for bone marrow failure, which can happen alongside PNH [5][6].
  • Lactate Dehydrogenase (LDH): This enzyme is found inside red blood cells. When PNH causes red blood cells to break apart (a process called hemolysis), LDH spills into your bloodstream [7]. While checking LDH is very useful for tracking cell destruction, it must be looked at alongside other tests, especially if you are on treatments where a normal LDH doesn’t always mean all hemolysis has stopped [1][4].
  • Reticulocyte Count: This measures the number of young, immature red blood cells your bone marrow is producing to replace destroyed cells [5][7].
  • Bilirubin and Haptoglobin: Indirect bilirubin often rises and haptoglobin drops during active hemolysis [7].
  • Other tests: Depending on your situation, your doctor may also regularly monitor your kidney function, iron status, or check your urine for blood, since ongoing hemolysis can affect these areas.

Monitoring Your PNH Clone Size

In PNH, a portion of your blood cells are missing the protective proteins that keep them safe from your immune system’s complement system. This group of unprotected cells is called your PNH clone.

To measure the percentage of your blood cells that are affected, doctors use a highly sensitive test called flow cytometry. This test measures clone size, not your current level of hemolysis [1].

  • Some guidelines suggest checking your clone size with flow cytometry once a year as one possible approach to see if your disease is evolving [1].
  • Your doctor may also order flow cytometry if your LDH levels suddenly spike, your anemia rapidly worsens, or you develop new, unexplained symptoms [5].

Important: A larger clone size does not automatically mean you will have more symptoms. It is just one piece of information your doctor uses to guide your care.

Times You May Need Extra Monitoring

Certain physical stressors can trigger a sudden increase in red blood cell destruction, known as breakthrough hemolysis. You should coordinate with your hematologist, as you may need extra monitoring if you:

  • Develop an infection or have surgery: These inflammatory events can increase complement system activity [8].
  • Receive a vaccination: Vaccines are very important, especially for PNH patients on certain therapies. Do not skip or delay vaccines. Instead, talk to your doctor about timing them appropriately, as they can sometimes trigger a temporary increase in hemolysis [8].
  • Start or change treatments: Such as complement inhibitors, to ensure the medication is properly protecting your cells [2][9].

If you develop persistent or unexplained worsening in your blood cell counts, your doctor might also recommend a bone marrow biopsy to check for underlying bone marrow failure [1][6].

Medical Emergencies in PNH

People with PNH are at a higher risk for dangerous blood clots (thrombosis). Routine blood tests and flow cytometry cannot diagnose or rule out a clot [5].
Seek emergency medical care immediately if you experience sudden chest pain, shortness of breath, severe or unusual abdominal or back pain, sudden swelling in one leg or arm, fainting, or new neurologic symptoms (like severe headache or confusion).

Safety note for patients on complement inhibitors: Drugs like terminal C5 inhibitors increase the risk of serious bacterial infections, like meningitis [2]. Seek urgent care for a high fever, severe headache, neck stiffness, rash, or rapidly worsening illness.

Common questions in this guide

How often will I need routine blood tests for PNH?
There is no single schedule for people with paroxysmal nocturnal hemoglobinuria. Your hematologist may order tests every few weeks or monthly when you are starting treatment or having active symptoms, while stable follow-up may require testing every 3 to 6 months.
Which blood tests are used to monitor PNH?
A complete blood count checks red cells, white cells, and platelets, while LDH, reticulocyte count, bilirubin, and haptoglobin help show red-cell destruction and the bone marrow response. Depending on your situation, your doctor may also check kidney function, iron levels, or urine for blood.
How often should PNH clone size be checked?
Flow cytometry measures the percentage of blood cells affected by the PNH clone, rather than measuring current red-cell destruction directly. Your hematologist may repeat it about once a year or sooner if LDH rises, anemia worsens quickly, or new unexplained symptoms develop; a larger clone does not automatically mean more symptoms.
Can pregnancy, infection, surgery, or vaccination mean I need extra PNH monitoring?
Yes. Pregnancy, infections, surgery, vaccination, and starting or changing complement-inhibitor treatment can lead to a need for closer monitoring. Pregnancy usually requires an individualized plan, and vaccines should not be skipped or delayed without discussing timing with your healthcare team.
Can routine blood tests rule out a blood clot caused by PNH?
No. Routine blood tests and flow cytometry cannot diagnose or rule out a blood clot. Sudden chest pain, shortness of breath, severe abdominal or back pain, one-sided limb swelling, fainting, or new neurologic symptoms require emergency medical care.
What infection symptoms are urgent if I take a terminal C5 inhibitor?
Terminal C5 inhibitors increase the risk of serious bacterial infections, including meningitis. Seek urgent medical care for a high fever, severe headache, neck stiffness, rash, or rapidly worsening illness.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Paroxysmal nocturnal hemoglobinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current symptoms and treatment, what is the best routine schedule for my blood work?
  2. 2.Which specific symptoms mean I should call your office, and which mean I should go to the emergency room?
  3. 3.When was my last flow cytometry test, and what is my current PNH clone size?
  4. 4.How do you monitor for other complications like bone marrow failure or kidney issues alongside my regular PNH blood tests?
  5. 5.What is our plan for monitoring my blood levels around major events like vaccinations, surgeries, or infections?

References

References (9)
  1. 1

    Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments.

    Fattizzo B, Marchetti M, Cannizzo E, et al.

    European journal of haematology 2026; doi:10.1111/ejh.70294.

    PMID: 42675626
  2. 2

    [Expert consensus on clonal screening and monitoring of complement inhibitor therapy in paroxysmal nocturnal hemoglobinuria (2024)].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2024; (45(2)):109-114 doi:10.3760/cma.j.cn121090-20230927-00145.

    PMID: 38604785
  3. 3

    Higher Doses of Eculizumab may be Beneficial in Paroxysmal Nocturnal Haemoglobinuria in Pregnancy.

    Patel HV, Stone S, Laird MC, et al.

    European journal of case reports in internal medicine 2025; (12(10)):005721 doi:10.12890/2025_005721.

    PMID: 41064707
  4. 4

    Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibition.

    Kulasekararaj AG, Kuter DJ, Griffin M, et al.

    Blood reviews 2023; (59()):101041 doi:10.1016/j.blre.2023.101041.

    PMID: 36732204
  5. 5

    Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.

    Wong RSM, Ho Jang J, Wong LLL, et al.

    International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252212160.

    PMID: 39596227
  6. 6

    Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.

    Shammo J, Gajra A, Patel Y, et al.

    Journal of blood medicine 2022; (13()):425-437 doi:10.2147/JBM.S361863.

    PMID: 35983240
  7. 7

    Paroxysmal Nocturnal Hemoglobinuria in a Young Adult Woman: A Representative Case of Recurrent Intravascular Hemolysis.

    Pera R, Lagarteira J, Sá S, et al.

    Cureus 2026; (18(1)):e100884 doi:10.7759/cureus.100884.

    PMID: 41658679
  8. 8

    Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.

    Dingli D, De Castro Iii C, Koprivnikar J, et al.

    Hematology (Amsterdam, Netherlands) 2024; (29(1)):2329030 doi:10.1080/16078454.2024.2329030.

    PMID: 39665683
  9. 9

    Non-capsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature.

    Galli N, Pettine L, Panigada M, et al.

    Frontiers in immunology 2023; (14()):1269325 doi:10.3389/fimmu.2023.1269325.

    PMID: 37854608

This page explains PNH blood-test monitoring for informational purposes only and does not constitute medical advice. Your hematologist should set your testing schedule and advise you when symptoms require urgent or emergency care.